Logo Image

Shorts

2026 AAN Annual Meeting: Trends to Watch
1:05
2026 AAN Annual Meeting: Trends to Watch
5 months ago
by
Paul George, MD, PhD, FAAN(+1 more)
Key Focus Areas of the 2026 AAN Meeting
1:12
Key Focus Areas of the 2026 AAN Meeting
5 months ago
by
Paul George, MD, PhD, FAAN(+1 more)
Emerging Concepts on the Horizon for Neurointerventional Surgery
1:28
Emerging Concepts on the Horizon for Neurointerventional Surgery
6 months ago
by
Marco Meglio(+1 more)
Functionality of Zeto One EEG Headset for Seizure Detection
1:28
Functionality of Zeto One EEG Headset for Seizure Detection
6 months ago
by
Marco Meglio(+1 more)
Clinical Considerations to Optimize Neurointerventional Surgery
1:28
Clinical Considerations to Optimize Neurointerventional Surgery
6 months ago
by
Marco Meglio(+1 more)
Emerging Targeted Therapies for Myasthenia Gravis
1:26
Emerging Targeted Therapies for Myasthenia Gravis
6 months ago
by
Isabella Ciccone, MPH(+1 more)
Design Considerations for Stem-Cell Based MS Trials
1:33
Design Considerations for Stem-Cell Based MS Trials
6 months ago
by
Jeffrey Cohen, MD(+1 more)
Phase 3 Updates for MASCOT Trial of MSA Agent Amlenetug
1:06
Phase 3 Updates for MASCOT Trial of MSA Agent Amlenetug
6 months ago
by
Marco Meglio(+1 more)
Why Pediatric Stroke Collaboration Matters
0:44
Why Pediatric Stroke Collaboration Matters
6 months ago
by
Beth Cavanaugh, MD(+1 more)
Understanding Mechanism of Investigational Lu AF28996 in Parkinson Disease
1:06
Understanding Mechanism of Investigational Lu AF28996 in Parkinson Disease
6 months ago
by
Marco Meglio(+1 more)
Recapping the 2026 ACTRIMS Forum
1:18
Recapping the 2026 ACTRIMS Forum
6 months ago
by
Isabella Ciccone, MPH(+1 more)
FDA Approval of High-Dose Nusinersen for Spinal Muscular Atrophy
1:06
FDA Approval of High-Dose Nusinersen for Spinal Muscular Atrophy
6 months ago
by
Marco Meglio(+1 more)
Living a Full Life with MS: Finding Hope and Specialized Care
1:25
Living a Full Life with MS: Finding Hope and Specialized Care
6 months ago
by
Constance V. Katsafanas, DO(+1 more)
Treating RLS Without Drug Interactions
1:07
Treating RLS Without Drug Interactions
6 months ago
by
Louie Pasculli(+1 more)
MS Roundtable: Educational Changes Needed With New Diagnostic Criteria
0:45
MS Roundtable: Educational Changes Needed With New Diagnostic Criteria
6 months ago
by
Marco Meglio(+1 more)
MS Roundtable: Treating Multiple Sclerosis Before Symptoms Arise
1:17
MS Roundtable: Treating Multiple Sclerosis Before Symptoms Arise
6 months ago
by
Marco Meglio(+1 more)
MS Roundtable: Top Takeaways From 2024 McDonald Criteria
1:17
MS Roundtable: Top Takeaways From 2024 McDonald Criteria
6 months ago
by
Marco Meglio(+1 more)
Purple Day: Exciting, Novel Treatments on the Horizon for Epilepsy
1:17
Purple Day: Exciting, Novel Treatments on the Horizon for Epilepsy
6 months ago
by
Marco Meglio(+1 more)
Overviewing Phase 3 DAWN Efficacy Data of Daratumumab in NMOSD
0:35
Overviewing Phase 3 DAWN Efficacy Data of Daratumumab in NMOSD
6 months ago
by
Michael Levy, MD, PhD(+1 more)
Why Some RLS Medications Can Make Symptoms Worse
0:58
Why Some RLS Medications Can Make Symptoms Worse
6 months ago
by
Louie Pasculli
Meeting the Needs of Underserved Multiple Sclerosis Populations
1:33
Meeting the Needs of Underserved Multiple Sclerosis Populations
6 months ago
by
Marisa McGinley, DO(+1 more)
Early Identification and Newborn Screening for Neuromuscular Disorders
0:37
Early Identification and Newborn Screening for Neuromuscular Disorders
6 months ago
by
John F. Brandsema, MD(+1 more)
Data Behind EBNA1 Antibodies as Distinguishable Feature of Multiple Sclerosis
2:00
Data Behind EBNA1 Antibodies as Distinguishable Feature of Multiple Sclerosis
6 months ago
by
Marco Meglio
4 FDA-Approved Treatments for NMOSD You Should Know
1:10
4 FDA-Approved Treatments for NMOSD You Should Know
6 months ago
by
Louie Pasculli
Clinical Value of EBNA1 Antibodies in MS, MOGAD, & NMOSD
1:24
Clinical Value of EBNA1 Antibodies in MS, MOGAD, & NMOSD
6 months ago
by
Marco Meglio
Emerging CAR-T Therapy Approaches in NMOSD
1:01
Emerging CAR-T Therapy Approaches in NMOSD
6 months ago
by
Louie Pasculli
Addressing Access Barriers to Emerging Therapies in Neuromuscular Disease
0:31
Addressing Access Barriers to Emerging Therapies in Neuromuscular Disease
6 months ago
by
Isabella Ciccone, MPH(+1 more)
Developing Pivotal Trials for Stem Cell-Based Agents in Multiple Sclerosis
1:33
Developing Pivotal Trials for Stem Cell-Based Agents in Multiple Sclerosis
7 months ago
by
Jeffrey Cohen, MD(+1 more)
MDA 2026: Accepting the MDA Legacy Award
0:48
MDA 2026: Accepting the MDA Legacy Award
7 months ago
by
Allison Moore(+1 more)
How Deramiocel Works
1:02
How Deramiocel Works
7 months ago
by
Noah Stansfield